Reference products and why people stop using them — neonatal hyperbilirubinemia home phototherapy

1. Summary

The domain dossier's own §5 already builds the core abandonment record for this domain's three device classes — fiberoptic blankets, wearable LED garments, and hospital bassinet units — from a ten-year FDA clearance-and-recall scan and two pooled meta-analyses. This report does not repeat that record. It reaches one registry layer the dossier's bounded ten-year window could not reach: the bili-hut's own 510(k) submission names its predicate as a home phototherapy device cleared in 1998, twenty-one years before the bili-hut itself and outside the LBI-code window the dossier scanned [1][2]. The same predicate manufacturer, Physician Engineered Products, Inc., carries a 2013 FDA recall on a second device for a labeling defect the dossier's aggregate recall count does not include, because that recall also predates its scan window [3][4]. Little Sparrows Technologies itself carries no FDA recall in a firm-specific query of the same registry [5], and the one US comparative trial named in the domain dossier turns out to be open-label by design [6].

2. What Changed

_Baseline (v1). No prior version; this establishes the starting point for future diffs._

3. Details

The bili-hut's predicate: a 1998 home-phototherapy clearance, outside the dossier's scan window

The domain dossier's §5 names the bili-hut (Little Sparrows Technologies, K190899) as a product line "not researched beyond its bare 510(k) listing." Read directly, the summary's own substantial-equivalence discussion states the comparison plainly:

"The bili-hut™ provides phototherapy for the treatment of neonatal hyperbilirubinemia... during the newborn period in the clinical or home setting. The intended use of the portable Ultra Bili Light™ model 2000 is to provide Home Phototherapy treatment for Neonatal Hyperbilirubinemia... both devices are indicated for treatment of neonatal hyperbilirubinemia in the hospital or home setting using blue light phototherapy... Use Intent: Multi-patient with disposables. Multi-patient with disposables. Same." — [1]

Two things follow directly from that text. First, the bili-hut's own predicate is a home phototherapy device — Physician Engineered Products, Inc.'s Ultra Bili Light, cleared under 510(k) K974830, decided 1998-05-20 [2] — meaning a lay-caregiver home phototherapy device was already on the US market through the 510(k) pathway a full generation before the fiberoptic- blanket and wearable-garment wave the domain dossier's ten-year clearance scan (2016-2026) covers. Second, both the bili-hut and its named predicate share a "multi-patient with disposables" use model — a reusable hardware unit paired with a disposable consumable — which is a third reuse pattern distinct from the single-patient fiberoptic blanket and the single-patient wearable garments (SnugLit, BiliWrap) the dossier's §5 already documents in detail.

A legacy manufacturer's own recall, outside the dossier's 2016-2026 window

Physician Engineered Products, Inc. is not named anywhere in the domain dossier's §8 market- players table. Its second product, the Bright Embrace Model SBL60 (K110550, decided 2012-02-03 [3]), carries an FDA device recall, initiated 2013-08-31, for the following stated reason:

"Upper limit for ambient temperature for use of the device was printed incorrectly in the instructions." — Recall Z-2486-2015; FDA-assigned root cause: Device Design [4]

This recall falls entirely outside the domain dossier's own 2016-2026 openFDA scan window for product code LBI, so it does not appear in that dossier's aggregate five-recall count — not because the record does not exist, but because the window used to build that count starts four years after this recall was initiated. It is also a different failure mode from every one already logged there: the dossier's five recalls concern fiberoptic-bundle degradation, light output below spec, and power-cord overheating in device hardware. This one concerns a labeling error in a home-use device's own stated safe operating temperature range — a failure mode specific to lay-caregiver use with no bedside nurse to catch a printed instruction that understates or overstates a thermal limit.

No FDA recall found for the current bili-hut

A firm-specific recall query for Little Sparrows Technologies, spanning the same ten-year class of window the domain dossier used for the broader LBI product code, returns zero records [5]. This is consistent with — and narrower confirmation of — the dossier's own finding that none of its five LBI-code recalls names Little Sparrows. An absence in this registry is what has not yet been recorded, not a statement that the device has no field issues; no MAUDE-narrative-level channel was queried in this pass (see §5).

The one named US comparative trial is open-label

The domain dossier records NCT03599258 (HonorHealth Research Institute, comparing Neolight Skylife to standardized phototherapy, completed 2021-05-27, no results posted) as the sole registered US comparative trial against a named commercial phototherapy device. The trial's own registry record adds a design detail the dossier does not state: the study is masked "NONE" — an open-label, unblinded, randomized, parallel-group design [6]. Combined with the already-recorded absence of posted results more than five years after completion, this is a second, independent reason the safety-endpoint data this trial was built to produce (skin irritation/ulceration, body- temperature maintenance) cannot yet be read as evidence of anything either way: it is both unpublished and, by its own registered design, unblinded when it eventually is.

4. Sources

[1] FDA 510(k) Summary K190899, bili-hut — Little Sparrows Technologies, Inc. (decided 2019-09-05; accessed 2026-09-01). K190899 — https://www.accessdata.fda.gov/cdrh_docs/pdf19/K190899.pdf [federal-registry] [2] FDA 510(k) K974830, Ultra Bili Light — Physician Engineered Products, Inc. (decided 1998-05-20; accessed 2026-09-01). K974830 — https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K974830 [federal-registry] [3] FDA 510(k) K110550, Bright Embrace Model SBL60 — Physician Engineered Products, Inc. (decided 2012-02-03; accessed 2026-09-01). K110550 — https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K110550 [federal-registry] [4] FDA device recall Z-2486-2015, Bright Embrace Model SBL60 — Physician Engineered Products, Inc. (recall initiated 2013-08-31; accessed 2026-09-01). Z-2486-2015 — https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm [federal-registry] [5] openFDA device/recall, recalling_firm="Little Sparrows" (queried 2026-09-01; accessed 2026-09-01), window 2016-09-04 to 2026-09-02, zero records — for the K190899 applicant — https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm [federal-registry] [6] ClinicalTrials.gov NCT03599258, Comparison of Phototherapy Using Neolight Skylife Versus Standardized Phototherapy for Hyperbilirubinemia in Newborns — HonorHealth Research Institute (status completed 2021-05-27; accessed 2026-09-01). NCT03599258 — https://clinicaltrials.gov/study/NCT03599258 [trial-registry]

5. Sourcing & Gaps

Well established: nothing in this report rests on two independent, non-affiliated primary sources — every line is one federal registry record read directly. Each is stated plainly rather than marked [single-source], matching this fleet's existing convention for a single registry record naming its own clearance, recall, or trial design (see the precedent set in the canine-equine-distal-limb-wounds and potassium-monitoring-ckd reference-products reports), which reserves [single-source] for a published finding that could in principle be corroborated by a second study, not for a registry entry that has no second registry to agree with it.

Thin: the "multi-patient with disposables" reuse-model reading in §3 comes from prose that survived an OCR-bounded extraction of the bili-hut's 510(k) summary rather than from a field FDA controls the same way it controls an Indications for Use statement — it is quoted verbatim so a reader can see exactly what was matched and overrule it. The recall root-cause label ("Device Design") is FDA's own classification field, not this report's characterization.

Rescoped from class 3: none newly rescoped in this report. This is a registry-facts report by construction (evidence_class: 1 registry); no stakeholder-future question was posed or needed rescoping.

Out of scope: MAUDE adverse-event narratives (no connector in this repo reaches them, per the domain dossier's own §10 provenance table); CPT descriptors; any non-US jurisdiction; the PATENTSVIEW_API_KEY-gated patent landscape (the key is unset in this environment).

Not searched vs. not found:

• Not found, in citable form: a trade-press report states that Natus Sensory acquired TheraB Medical (maker of the SnugLit wearable named in the domain dossier's §5 and §8) on or around 2026-02-12, retrieved directly from a medical-device trade publication. It carries no PMID, NCT, K-number, CFR section, HCPCS code, DOI, CELEX number, or Federal Register document number to resolve to, and none could be located for it, so it is disclosed here rather than numbered in §4, consistent with this fleet's existing treatment of an equivalent uncitable web finding in the canine-equine-distal-limb-wounds reference-products report. If confirmed by a primary corporate filing or FDA establishment-registration change, it would mean the newest wearable entrant and the incumbent fiberoptic-blanket manufacturer (Natus, the applicant behind the neoBLUE line the dossier's §5 already documents) share a parent company within a month of the wearable's clearance — a market-players-section question, not resolved here.
• Not found, in citable form: retail and resale listings located by search show a bili-hut list price and heavily inconsistent secondary-market prices for the neoBLUE blanket, none of them a manufacturer invoice, a DME reimbursement rate, or a page carrying a resolvable identifier. No price is stated as fact in §3 for this reason; the domain dossier's own reimbursement section already carries the one sourced payment figure available (a Louisiana Medicaid HCPCS E0202 line item), which this report does not repeat.
• Not searched: individual 510(k) summary text for K110550 (Bright Embrace) — the summary PDF returned HTTP 401/404 at both of its expected repository paths, an FDA-repository-completeness gap the clearance-summary connector documents rather than a negative finding about the device; a US-population bili-hut or Ultra-Bili-Light outcome study; whether Physician Engineered Products, Inc. still manufactures either device today.

[inference] Framing the bili-hut/Ultra Bili Light and Bright Embraces as a distinct "third reuse pattern" alongside the fiberoptic blanket and the wearable garments is this report's own synthesis of two registry records, not a conclusion stated by either 510(k) record itself.

6. Claim Candidates